Navigation Links
BurgessGroup Announces Contract Renewal and Software Upgrade by CalOptima
Date:4/1/2008

ALEXANDRIA, Va., April 1, 2008 /PRNewswire-USNewswire/ -- BurgessGroup, a leading Medicare-based data and information technology solutions firm, announced today the signing of a three-year contract renewal with CalOptima, a client since June 2005. CalOptima is an Orange County, California-based public agency created by the state of California's Medicaid program, Medi-Cal.

CalOptima is one of five County Organized Health Systems (COHS) in the country, and is authorized by federal law to administer Medi-Cal benefits. Through the efficient use of available state and federal funds and the assessing of needs on a local community basis, CalOptima has the ability to provide its members wider access to healthcare providers.

Under the renewed contract, CalOptima will continue to be a licensed user of the Burgess Reimbursement System (BRS), integrating solutions for Inpatient Hospital (DRG-based) and Home Health provider payments and adding BurgessGroup's automated BRS BatchPricer. BurgessGroup will also continue to provide ongoing technical and Medicare payment policy support and education. Historically, CalOptima has utilized BRS for fee schedule creation, Medicare Advantage claims reimbursement, and provider relations purposes. BRS is the only Medicare-based pricing and analysis software in the industry covering all major prospective payment systems.

"One of the primary reasons we are continuing to work with Burgess is the ease of their tool. It's very user friendly, which is a huge asset for claims processing," stated Cara Chastain, Strategic Communications Manager, CalOptima. "Their BatchPricer solution will allow us the ability to build and improve auto-adjudication of claims."

"We are pleased and excited to continue working with CalOptima," commented Greg Burgess, Managing Partner, BurgessGroup. "BurgessGroup prides itself on delivering best-of-breed solutions and developing lasting, extraordinary relationships with our client
'/>"/>

SOURCE BurgessGroup
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...me up with a novel idea to boost up the sales of t...are. He has announced a handsome reward of Rs. 100...ate.// "No bird flu case has been registered in t...mport has been banned in the state. We offer a rew...
...vaccinated against diphtheria-tetanus-pertussis. T... causes a red splotch to develop on the area. Thi...that// neither of two common drugs--ibuprofen (Adv...prevent this side effect. A Group Health Cooperati...
... as about 3,000 people in the steel town were affe...irst reported in a small group at a slum// cluster...or its steel plant, Monday. Since then, it has rap...of the town. The high fever is accompanied by vom...
...that stem cell therapy for heart attack may not be...under rigorous conditions//. German researchers ha... improve cardiac function following heart attack. ...ics have had the potential to attract the attentio...
Other Medicine News:Health News:Allergic reaction to DTaP vaccine persists in children 2Health News:Stem Cell Therapy For Heart Attack Found To Be Ineffective 2
(Date:10/6/2008)...with Durezol Dosed Prior to Surgery, TAMPA, Fla.,... a,privately held ophthalmic-focused biopharmaceut...fluprednate ophthalmic emulsion) 0.05% is now,comm... the U.S. Food and,Drug Administration in June 200...d for the treatment of inflammation and pain assoc...
(Date:10/6/2008)...e to severe patients achieved endoscopic,response ...sion at Week 10,in data from a 54-week open-label ...nterology (ACG) Annual Scientific Meeting, ORLAND...d data from a,large, prospective study investigati...with a biologic compound. The data presented at th...
(Date:10/6/2008)...stCall/ -- Dendreon Corporation (Nasdaq:,DNDN) wil... 2008 at 9:00 AM,ET (6:00 AM PT) to review the out...therapy for Prostate AdenoCarcinoma Treatment, als...sipuleucel-T), the Company,s investigational,activ...nced prostate,cancer., Those interested may ac...
(Date:10/3/2008)...s the newest study site, PHILADELPHIA, Oct. 3 /PR... Philadelphia today received a contract to manage ... Children,s Hospital will manage local,participati...County, New,Jersey. The study is funded by the Nat...pate approximately 1,000 families in Burlington,Co...
Breaking Medicine Technology:Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 1Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 2Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 3Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 4Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 5Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 6Stress may increase a womans risk of developing cervical cancer 12083 1Stress may increase a womans risk of developing cervical cancer 12083 2Daily Stress May Raise Womens Risk of Cervical Cancer 12080 1Daily Stress May Raise Womens Risk of Cervical Cancer 12080 2Daily Stress May Raise Womens Risk of Cervical Cancer 12080 3A map of the worm 3A First detailed anatomical atlas of C elegans for use in the lab 12077 1A map of the worm 3A First detailed anatomical atlas of C elegans for use in the lab 12077 2
...ease Week -, CAMBRIDGE, Mass., May 21, 2007 /PRNew...n of data from a Phase 2 study in which,linaclotid...unction,in patients with constipation- predominant... showed linaclotide was well tolerated with,a low ...t-in-class,compound currently being developed for ...
...rom phase III,clinical trials and further human ph...ress of the European Academy of,Dermatology and Ve...acy and safety profile of alitretinoin as a potent...vere refractory chronic,hand eczema. , Currently, ...nd,Eczema (CHE) refractory or unresponsive to topi...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5
Helmer's Horizon Series Plasma Storage Freezers HPF 125-4 incorporate solid performance and value. They feature a microprocessor-based independent temperature controller and alarm/monitor system with
Plasma Blast Chest Freezer -50C - 8098/8091 maintains a -50C (-58F) temperature to rapidly freeze single donor, apheresed, and fresh frozen plasma. Rapid freezing also preserves Factor VIII. Full loa
...for digital histology. It consists of a scanner, a...software modules. At the heart of MIRAX SCAN lies ...s Digital Slides. Any time, from any place. In bri...s on a microscope. The Digital Slide will revoluti...
... incorporates detection of T-wave alternans (TWA) ...nalysis tools. Premier 12 makes a complete 24-hour... provides visualization of the actual TWA, for vis... detects two modes of TWA: the beat-to-beat change...
Medicine Products: